Almirall (WBO:ALM) ROCE %: 5.56% (As of Mar. 2026)

What is Almirall ROCE %?

Almirall WBO:ALM +0.72% 85 ROCE % is 5.56% as of Mar. 2026. GuruFocus rates WBO:ALM with a GF Score™ of 85/100 and a GF Value™ of €12.37. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Almirall's annualized ROCE % for the quarter that ended in Mar. 2026 was 5.56%.

Almirall (WBO:ALM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Almirall ROCE % Related Terms

Almirall ROCE % Historical Data

* Premium members only.

The historical data trend for Almirall's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Almirall ROCE % Chart

Almirall Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROCE %

Get a 7-Day Free Trial

0.21

2.06

-0.51

1.71

4.11

Almirall Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROCE %	Get a 7-Day Free Trial															7.72	1.73	5.63	7.78	5.56

85GF Score

Almirall SA WBO:ALM

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Almirall ROCE % Calculation

Almirall's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2025 )		(A: Dec. 2024 )		(A: Dec. 2025 )
	=	82.81	/	( ( (2396.663 - 353.424)	+	(2337.134 - 350.639) )	/ 2 )
	=	82.81	/	( (2043.239	+	1986.495)	/ 2 )
	=	82.81	/	2014.867
	=	4.11 %

Almirall's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2026 )		(Q: Dec. 2025 )		(Q: Mar. 2026 )
	=	111.6	/	( ( (2337.134 - 350.639)	+	(2330 - 301.9) )	/ 2 )
	=	111.6	/	( ( 1986.495	+	2028.1 )	/ 2 )
	=	111.6	/	2007.2975
	=	5.56 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 5.56% mean?

Almirall (WBO:ALM) has a ROCE % of 5.56% as of Mar. 2026.

Is Almirall's ROCE % too high?

Almirall's current ROCE % is 5.56%. The Drug Manufacturers industry median ROCE % is 7.00. Almirall's value of 5.56% is 20.5% below this industry median. Overall, Almirall has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.

How does Almirall's ROCE % compare to ZTS and UTHR?

Almirall's ROCE % of 5.56% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. Almirall's value of 5.56% is 20.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Drug Manufacturers company?

The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Almirall's current ROCE % of 5.56% is 20.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Almirall's current ROCE % is 5.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Almirall stock overvalued right now?

Almirall (WBO:ALM) has a current ROCE % of 5.56%. The stock's GF Value™ is €12.37, compared to a current price of €11.22 — trading 9.3% below its estimated fair value. The current ROCE % is 5.56% and 20.5% below the Drug Manufacturers industry median of 7.00. Almirall's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Almirall (WBO:ALM), the current ROCE % is 5.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Almirall (WBO:ALM) Overvalued in 2026?

Based on GuruFocus' analysis, Almirall stock appears to be undervalued. The current stock price of €11.22 is trading 9.3% below its estimated GF Value™ of €12.37.

Key valuation signals for WBO:ALM:

ROCE %: 5.56%
GF Value™: €12.37 vs. price of €11.22 (9.3% below fair value)
GF Score™: 85/100 with 4 warning signs
Industry Position: 20.5% below the Drug Manufacturers median

No single metric tells the full story. See the WBO:ALM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Almirall Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies XMAD:ROVI XMAD:FAE XMAD:RJF XMAD:LAB XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692 UTHR VTRS NSE:DIVISLAB OSTO:SOBI TSE:4507 NBIX

Other Exchanges 0O9B:UK ALM:Spain E2Z:Germany

Address Ronda General Mitre 151, Barcelona, ESP, 08022

Website http://www.almirall.es

Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.

85GF Score

Get the complete analysis for WBO:ALM

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€11.22

Price

€12.37

GF Value

View WBO:ALM Analysis

See ROCE % data for all stocks →